Overview

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

Status:
Completed

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the safety and efficacy of ABT-719 in preventing acute kidney injury in patients undergoing high risk cardiac surgery.

Phase:

Phase 2

Details

Lead Sponsor:

AbbVie